Figures & data
Figure 1. Structure of the Model for Predicting Cost Effectiveness. Abbreviations. ED, emergency department; OCS, oral corticosteroids.
![Figure 1. Structure of the Model for Predicting Cost Effectiveness. Abbreviations. ED, emergency department; OCS, oral corticosteroids.](/cms/asset/9db03078-0148-4afa-babc-41d915e9465c/ijme_a_1760285_f0001_b.jpg)
Table 1. Regular OCS Inputs in the Base Case Model.
Table 2. Results from Base Case Cost-effectiveness Analysis.
Figure 2. Cost-effectiveness Plane for Benralizumab vs. SOC Plus OCS from Probabilistic Sensitivity Analysis. Abbreviations. OCS, oral corticosteroids; QALY, quality-adjusted life-year; SEK, Swedish Kronor (2018); SOC, standard of care. Values shown indicate the uncertainty around the incremental cost-effectiveness ratio.
![Figure 2. Cost-effectiveness Plane for Benralizumab vs. SOC Plus OCS from Probabilistic Sensitivity Analysis. Abbreviations. OCS, oral corticosteroids; QALY, quality-adjusted life-year; SEK, Swedish Kronor (2018); SOC, standard of care. Values shown indicate the uncertainty around the incremental cost-effectiveness ratio.](/cms/asset/36fbb48a-c2a5-4519-a237-38c8ca7ae6f8/ijme_a_1760285_f0002_b.jpg)